Cadrenal Therapeutics, Inc. 10-K filing
Filed 2026-03-31 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001213900-26-036946
- Form type
- 10-K
- CIK
- 0001937993
- Primary document
- https://www.sec.gov/Archives/edgar/data/1937993/000121390026036946/ea0283741-10k_cadrenal.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Cadrenal Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-13.5M | - | - |
| Net Income | $-13.2M | - | - |
| Eps Basic | -6.64 | - | - |
| Eps Diluted | -6.64 | - | - |
| Cash And Equivalents | $4.0M | - | - |
| Total Assets | $4.3M | - | - |
| Total Liabilities | $1.6M | - | - |
| Shareholders Equity | $2.7M | - | - |
| Operating Cash Flow | $-12.6M | - | - |
| Capital Expenditures | $5,104 | - | - |